Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.
Frederick S Barrett, Hollis Robbins, David Smooke...
https://pubmed.ncbi.nlm.nih.gov/28790944/Actively Recruiting
Led by Johns Hopkins University · Updated on 2026-09-15
100
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are investigating how personally meaningful autobiographical music compares with standardized playlists during psilocybin sessions in healthy adults aged 21 to 75. The study aims to understand whether autobiographically salient music produces stronger emotional responses, greater subjective effects, and longer-lasting improvements in mood and well-being, as well as how brain and body responses vary with different music types under psilocybin. Participants will take a single 25 mg oral dose of psilocybin and listen to one of five different six-hour music playlists, including three with autobiographically salient music placed at varying times during the six-hour session, a standardized Johns Hopkins playlist, or an ambient playlist without autobiographical content. The music is delivered while participants recline in a comfortable setting during the 6-hour session. During the study, participants will complete questionnaires on emotions and subjective effects, undergo EEG and physiological monitoring including respiration, heart rate, and skin conductance, and have MRI brain scans before and one week after psilocybin administration. Follow-ups occur at 1 day, 1 week, and 1 month after the session, including a qualitative interview and a nondrug EEG music listening session. Researchers will measure various psychological and physiological outcomes immediately after and during the session, as well as longer-term effects on mood, well-being, and brain activity.
CONDITIONS
PRoMiSS: Psilocybin and the Role of Music in Set and Setting
D
David S Rosen, PhD
S
Sabina Vitola, M.S.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Johns Hopkins University
Lead Sponsor
Steven & Alexandra Cohen Foundation
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | PRoMiSS investigational regimen | External standard context |
|---|---|---|
| What it is | A single‑group experimental design delivering one high‑dose psilocybin session (25 mg) accompanied by one of several curated six‑hour music playlists | Music‑assisted psilocybin therapy typically delivers a structured psychedelic session using music to support emotional processing and mystical‑type experiences |
| Role in this trial | Primary investigational intervention combining psilocybin with music playlists | Not part of this study design, included only as external clinical context |
| Primary purpose | Exploring the interplay of psilocybin and music in influencing acute psychedelic experience | Support emotional integration and enhance psychedelic session depth in psilocybin therapy |
| How it is given or performed | Participants receive a single oral 25 mg psilocybin pill while listening to a curated six‑hour playlist | Sessions typically pair orally administered psilocybin with a carefully sequenced supportive music playlist over several hours |
| Evidence status | Evidence pending; outcomes include subjective experience scales, EEG changes, and psychological questionnaires | Preliminary observational and qualitative studies suggest music enhances therapeutic emotion and mystical‑type experiences |
| Important limitations | No control group; music playlists vary across participants; inability to isolate music versus drug effects | Lack of standardized music protocols and small sample sizes limit generalizability |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 hours
Participants take a single 25 mg oral dose of psilocybin and listen to one of five six-hour music playlists while reclining comfortably. EEG and physiological monitoring occur throughout the session.
1 session (in-person)
Duration - 1 month
Participants complete questionnaires and interviews assessing emotions, mood, well-being, and psychological insights. MRI scans are done before and one week after the session, with additional EEG music listening and interviews at one month.
Multiple visits including 1-day, 1-week, and 1-month follow-ups
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Frederick S Barrett, Hollis Robbins, David Smooke...
https://pubmed.ncbi.nlm.nih.gov/28790944/Mendel Kaelen, Bruna Giribaldi, Jordan Raine...
https://pubmed.ncbi.nlm.nih.gov/29396616/Frederick S Barrett, Kevin J Grimm, Richard W Robins...
https://pubmed.ncbi.nlm.nih.gov/20515227/Tasha L Golden, Susan Magsamen, Clara C Sandu...
https://pubmed.ncbi.nlm.nih.gov/35138585/Johns Hopkins University
Lead Sponsor
Steven & Alexandra Cohen Foundation
Collaborating Sponsor